citrulline and pasireotide

citrulline has been researched along with pasireotide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berbée, M; Boerma, M; Fu, Q; Hauer-Jensen, M; Schmid, HA; Wang, J	1

Other Studies

1 other study(ies) available for citrulline and pasireotide

Article	Year
The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion. Radiation research, 2009, Volume: 171, Issue:6 Topics: Animals; Bacterial Translocation; Blood Cells; Cesium Radioisotopes; Chemokine CXCL9; Citrulline; Dose-Response Relationship, Radiation; Interleukin-12; Intestinal Mucosa; Jejunum; Kaplan-Meier Estimate; Liver; Male; Mice; Pancreas; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Somatostatin; Thermoluminescent Dosimetry; Treatment Outcome; Whole-Body Irradiation	2009

Article

Year

The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion.

Radiation research, 2009, Volume: 171, Issue:6

Topics: Animals; Bacterial Translocation; Blood Cells; Cesium Radioisotopes; Chemokine CXCL9; Citrulline; Dose-Response Relationship, Radiation; Interleukin-12; Intestinal Mucosa; Jejunum; Kaplan-Meier Estimate; Liver; Male; Mice; Pancreas; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Somatostatin; Thermoluminescent Dosimetry; Treatment Outcome; Whole-Body Irradiation

2009